75283-40-8 Usage
Uses
Used in Pharmaceutical Industry:
[(5E)-2-oxoocta-5,7-dien-1-ylidene]diazenium is used as a nitric oxide donor for its potential applications in the pharmaceutical industry. Nitric oxide is a signaling molecule that plays a crucial role in various physiological processes, including vasodilation, immune response, and neurotransmission. As a nitric oxide donor, [(5E)-2-oxoocta-5,7-dien-1-ylidene]diazenium could be utilized in the development of drugs targeting conditions such as hypertension, erectile dysfunction, and certain inflammatory diseases.
Used in Biomedical Research:
In the field of biomedical research, [(5E)-2-oxoocta-5,7-dien-1-ylidene]diazenium is used as a research tool to study the role of nitric oxide in various biological processes. Its ability to release nitric oxide makes it a valuable compound for investigating the mechanisms underlying nitric oxide-mediated cellular signaling, as well as its potential therapeutic applications in treating diseases associated with nitric oxide dysregulation.
Used in Drug Delivery Systems:
Similar to gallotannin, [(5E)-2-oxoocta-5,7-dien-1-ylidene]diazenium could be employed in the development of novel drug delivery systems to enhance its applications and efficacy. By incorporating [(5E)-2-oxoocta-5,7-dien-1-ylidene]diazenium into various organic and metallic nanoparticles, researchers can improve its delivery, bioavailability, and therapeutic outcomes, potentially leading to more effective treatments for a range of conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 75283-40-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,2,8 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 75283-40:
(7*7)+(6*5)+(5*2)+(4*8)+(3*3)+(2*4)+(1*0)=138
138 % 10 = 8
So 75283-40-8 is a valid CAS Registry Number.
75283-40-8Relevant academic research and scientific papers
Hudlicky, Tomas,Koszyk, Francis J.,Kutchan, Toni M.,Sheth, Jagdish P.
, p. 5020 - 5027 (1980)
Initial model studies investigating the utility of a new intramolecular cyclopentene annulation procedure are described as pertaining to the preparation of bicyclooctenones.Several 1-diazo-5,7-octadien-2-ones substituted at the 1-, 7-, or 8-position were decomposed in the presence of Cu(acac)2 to yield stereospecifically the corresponding vinylcyclopropanes 13, 16, 21, 24, and 27.The thermal as well as the rhodium-promoted modes of rearrangement to the appropriate cyclopentenes 14, 17, 22a,b, and 28a,b were studied.Where necessary, diastereomers were separatedand structurally assigned by relying on 13C NMR spectroscopy. 13C NMR data are provided for all new compounds in the bicyclooctane series to serve as an aid in assignments of cyclopentanoid terpenes synthesized by this methodology.The intramolecular cylopropanation-rearrangement sequence of dienic diazo ketones has been shown to provide facile access to bicyclooctanes of the type 14, 17, 22a,b, and 25a,b which are of value as terpene synthons.Enhanced stereoselectivity was observed in the rhodium-promoted cyclopentene rearrangements in favor of the less concave diastereomers (22a, 25a, and 28a).Finally, the sesquiterpene hirsutene (31) was synthesized in 37percent overall yield by this methodology. 13C NMR data for several tricyclo2,6>undecane compounds are also provided.
